Repurposed Drug Could Open Door to More Stem Cell Transplants

News   Dec 21, 2017 | Original story from University of British Columbia

 
Repurposed Drug Could Open Door to More Stem Cell Transplants

This is Peter Zandstra, director of UBC's School of Biomedical Engineering and Michael Smith Laboratories, and chief scientific officer of the Centre for Commercialization of Regenerative Medicine. Credit: UBC/Paul Joseph

 
 
 

RELATED ARTICLES

Lunaphore and Vitro Sign Collaboration Agreement

News

Companies announce a collaboration agreement to develop In Situ Hybridization (ISH) protocols for RNA and DNA targets in tissue using reagents provided by Vitro on Lunaphore’s rapid autostaining platform.

READ MORE

Worldwide Clinical Trials Receives 2018 CRO Leadership Awards

News

Life Science Leader and Industry Standard Research assess 70 contract research organizations, honoring Worldwide Clinical Trials for fifth consecutive year.

READ MORE

Tuberculosis: Pharmacists Develop Substance to Counteract Antimicrobial Resistance

News

Antimicrobial resistance is on the rise worldwide. This is becoming a problem for infectious diseases like tuberculosis as there are only a few active substances available to combat such diseases. Pharmacists have now found a way to increase the efficacy of a common tuberculosis agent while, at the same time, reducing resistance to it.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE